
Moberg Pharma AB (publ) (MOB.ST)
MOB.ST Stock Price Chart
Explore Moberg Pharma AB (publ) interactive price chart. Choose custom timeframes to analyze MOB.ST price movements and trends.
MOB.ST Company Profile
Discover essential business fundamentals and corporate details for Moberg Pharma AB (publ) (MOB.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
26 May 2011
Employees
10.00
Website
https://www.mobergpharma.seCEO
Anna Ljung BA,
Description
Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products in Europe, the United States, and internationally. It develops MOB-015, which has completed Phase III clinical trial for the treatment of nail fungus. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is headquartered in Bromma, Sweden.
MOB.ST Financial Timeline
Browse a chronological timeline of Moberg Pharma AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 9 Feb 2026
Upcoming earnings on 11 Nov 2025
Earnings released on 12 Aug 2025
EPS came in at -kr 0.15 falling short of the estimated -kr 0.10 by -53.85%, while revenue for the quarter reached kr 3.60M , missing expectations by -5.37%.
Earnings released on 13 May 2025
EPS came in at -kr 0.06 , while revenue for the quarter reached kr 3.87M , missing expectations by -3.28%.
Earnings released on 11 Feb 2025
EPS came in at kr 1.21 surpassing the estimated -kr 0.12 by +1.11K%, while revenue for the quarter reached kr 1.03M , beating expectations by +71.17%.
Earnings released on 12 Nov 2024
EPS came in at -kr 0.03 surpassing the estimated -kr 0.10 by +70.00%, while revenue for the quarter reached kr 3.86M , missing expectations by -3.63%.
Earnings released on 13 Aug 2024
EPS came in at -kr 0.13 , while revenue for the quarter reached kr 4.11M .
Earnings released on 7 May 2024
EPS came in at -kr 0.14 , while revenue for the quarter reached kr 820.00K .
Earnings released on 13 Feb 2024
EPS came in at -kr 0.23 .
Earnings released on 7 Nov 2023
EPS came in at -kr 0.36 .
Stock split effective on 11 Aug 2023
Shares were split 3 : 2 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 3 Aug 2023
EPS came in at -kr 0.26 .
Stock split effective on 24 May 2023
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 May 2023
EPS came in at -kr 0.34 .
Earnings released on 7 Feb 2023
EPS came in at -kr 0.21 .
Earnings released on 8 Nov 2022
EPS came in at -kr 0.04 , while revenue for the quarter reached kr 207.00K .
Earnings released on 9 Aug 2022
EPS came in at -kr 0.06 .
Earnings released on 10 May 2022
EPS came in at -kr 0.09 .
Stock split effective on 10 May 2022
Shares were split 207 : 200 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 8 Feb 2022
EPS came in at -kr 0.10 falling short of the estimated kr 1.00 by -109.95%.
Earnings released on 9 Nov 2021
EPS came in at -kr 0.87 surpassing the estimated -kr 1.68 by +48.32%.
Earnings released on 10 Aug 2021
EPS came in at -kr 0.74 .
Earnings released on 11 May 2021
EPS came in at kr 4.46 .
Earnings released on 9 Feb 2021
EPS came in at -kr 3.26 , while revenue for the quarter reached -kr 16.83M .
Stock split effective on 2 Dec 2020
Shares were split 113 : 100 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 10 Nov 2020
EPS came in at -kr 2.39 .
MOB.ST Stock Performance
Access detailed MOB.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.